ChenTai Advanced Materials Secures Tens of Millions of RMB in New Funding from Bilinxing Venture Capital and Zhongxin Capital

Investment Circle (ID: pedaily2012) January 16th news, TrendTec (referred to as "TrendTec"), after announcing in December 2024 the completion of over 100 million yuan in financing from Vivo Capital and funds under CICC Capital, has continued to gain capital favor. Recently,Continued to introduce well-known investors Proxima Capital and Zhongxin Capital, with a transaction amount reaching tens of millions of RMB.

TrendTec specializes in the research, development, production, and sales of high-performance ceramic materials for medical applications, providing high-performance bioceramic materials and components to medical device companies both in China and internationally. The company’s founder, Dr. Zhang Lin, and co-founder, Dr. Cao Xiaogang, both graduated from the Materials Science program at Tsinghua University. They are currently members of the Ceramic Implant Materials Standards Working Group (WG3) under the National Technical Committee for Standardization of Surgical Implants and Orthopedic Devices (SAC/TC110) in China, responsible for formulating relevant industry standards.

As of August 2024, TrendTec's flagship powder ceramic products have completed the main documentation filing with the National Medical Products Administration (NMPA). As one of the first material manufacturers in China to complete the main documentation filing, TrendTec has met the conditions for downstream manufacturers to register. With a fully localized production process in China, TrendTec’s products offer significant cost advantages compared to similar products from foreign enterprises, providing downstream manufacturers with more cost-effective material solutions.

In addition to fine alumina powder, the company has also developed various innovative ceramic material products, which will provide higher-quality upstream raw materials for more manufacturers. TrendTec is committed to becoming an outstanding domestic enterprise that breaks the monopoly of imported products and contributes to the development of China's high-performance composite ceramic industry.

Dr. Zhang Lin, Founder of TrendTecRepresentation: We are very grateful for the continued recognition from the capital market for TrendTec, and we thank our new and existing shareholders for their strong support. We will continue to work hard with the mission of "envisioning the future of medical technology and providing quality health support to more people" and the vision of "becoming a leader in the field of bioceramics." We will deepen technological innovation and enhance core competitiveness, living up to the trust placed in us by the nation and our shareholders, while contributing to the development of China's high-performance composite ceramics industry.

Proxima Capital's project leader, Li Qian, stated:In the upstream of the artificial joint industry, the "powdered ceramic" ball heads and liners have long been monopolized by imported manufacturers. Relying on the profound technical accumulation of two Tsinghua University materials science Ph.D.s over the past 20-plus years, TrendTec has successfully developed and mass-produced powdered ceramic femoral heads and liners. The performance of their products is on par with international leading enterprises, yet the cost is significantly lower than that of imported manufacturers. We firmly believe that TrendTec, which shoulders the important task of solving the "bottleneck" problem, is expected to break the monopoly of imported joint materials. With its excellent cost-performance ratio, TrendTec is poised to become the preferred partner of joint manufacturers, enabling them to continuously provide high-quality products to the market.

Gu Chengyu, the project leader of Proxima Capital, said:The upstream raw materials of China's artificial joint industry have long been monopolized by imported manufacturers, which has constrained the continuous development of the industry. We are very pleased to note that TrendTec, as a start-up company, has excellently filled this key link in the industrial chain with its products. We believe that in the future development, more and more artificial joint companies will use core components from domestic suppliers, enhancing the independent and controllable capabilities of the entire industry. We will also work hand-in-hand with the company to help TrendTec reach new heights.

Dr. Guowen Zou, founder of Proxima Capital, stated:In the current capital winter, it is not easy to gain recognition from two rounds of well-known investment institutions in a short period. We are honored to have continuously accompanied such an outstanding enterprise as TrendTec, witnessing such a brilliant moment in the capital market. This fully demonstrates the significant importance of mastering core upstream technologies for China's medical device industry.